-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the past 40 years, the incidence of esophageal adenocarcinoma, including cardia adenocarcinoma, has increased rapidly in Western countries, while the incidence of another major histological type of esophageal cancer-esophageal squamous cell carcinoma has increased.
The main risk factors for esophageal adenocarcinoma include gastroesophageal reflux disease, obesity, and smoking.
The main risk factors for esophageal adenocarcinoma include gastroesophageal reflux disease, obesity, and smoking.
In this study, the researchers aimed to verify the hypothesis that MHT reduces the risk of esophageal adenocarcinoma
The researchers aimed to verify the hypothesis that MHT reduces the risk of esophageal adenocarcinoma
The correlation between menopausal hormone therapy and the risk of esophageal adenocarcinoma and esophageal squamous cell carcinoma
The correlation between menopausal hormone therapy and the risk of esophageal adenocarcinoma and esophageal squamous cell carcinomaThe results showed that the study cohort included 296,964 menopausal hormone therapy users and 1,484,820 non-users
Menopausal hormone therapy users generally reduced the risk of esophageal adenocarcinoma (HR=0.
Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study
Leave a message here